Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Recovery-Oriented Counselling Group

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03925181
Recruitment Status : Active, not recruiting
First Posted : April 24, 2019
Last Update Posted : December 8, 2021
Sponsor:
Collaborator:
Alberta Health Services
Information provided by (Responsible Party):
Tanya Mudry, University of Calgary

Brief Summary:
The purpose of this study is to evaluate a recovery-oriented group counselling program for post-discharged critical illness survivors and their caregivers.

Condition or disease Intervention/treatment Phase
Post-Intensive Care Recovery Behavioral: Counselling Group Not Applicable

Detailed Description:

The purpose of this pilot project is to develop and evaluate a recovery-oriented counselling group to support the physical, emotional, and social recovery processes of critical care survivors who access the services of the Calgary ICU Recovery Clinics. Upon discharge, critical care survivors are faced with challenges related to their stay in the Intensive Care Unit (ICU), as well as long-term recovery from critical illness. These challenges impact survivors' physical, emotional, social recovery processes, which reduce quality of life, delay (re)integration into their communities, and cause further health problems. Social support and counselling groups show therapeutic promise in supporting recovery processes by increasing social connection, quality of life, acquisition of skills, and emotional and psychological wellbeing.

The purpose of this study is to evaluate a recovery-oriented group counselling program for post-discharged critical illness survivors and their caregivers. The investigators will utilize Substance Abuse and Mental Health Service Administration's (SAMHSA) evidence-based recovery curriculum to develop a counsellor-facilitated recovery-oriented group for patients and caregivers focusing on peer support, relationships, evidence-based strategies, daily life, purpose and meaning-making, strengths, and resilience.

The research objectives are:

  • Implement a recovery-oriented counselling group for ICU Recovery Clinic patients and their caregivers.
  • Evaluate the recovery-oriented counselling group as situated within the Calgary ICU Recovery Clinic.

The investigators will utilize a Randomized Controlled Trial (RCT) design (non-clinical trial). Participants will be randomized into a treatment (intervention) or wait-list control group. Participants in the wait-list control group will be offered the intervention after the treatment group has completed the intervention group. The investigators will evaluate the intervention through the use of outcomes measures currently used by the ICU Recovery Clinic in a pre-test (t0), immediate post-test (t1), 3-month (t2), and 6-month (t3) follow-ups. In addition, the investigators will conduct a process evaluation of the intervention via content analysis of audio recorded data from semi-structured interviews and focus groups with participants. Patients and caregivers will participate in separate focus groups.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 17 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Intervention Model Description: In total, 12 ICU survivors will be recruited along with their 12 caregivers. Once participants have been recruited, they (and their caregivers) will be randomly assigned to 2 arms: intervention or no intervention (waitlist control). The waitlist control group will receive the intervention in the second arm after the first intervention arm is complete.
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: A Recovery-Oriented Counselling Group: Supporting Physical, Emotional, and Social Recovery Processes of Critical Care Patients in the ICU Recovery Clinic
Actual Study Start Date : June 12, 2019
Actual Primary Completion Date : December 7, 2021
Estimated Study Completion Date : December 31, 2021

Arm Intervention/treatment
Experimental: Intervention
Recovery counselling group.
Behavioral: Counselling Group
All sessions will be based off of SAMHSA's recovery curriculum but tailored to the participants recovering from the ICU and their caregivers. Throughout the 6-weeks, the sessions will be holistic, strengths-based, hopeful, respectful, relational, and subjective, while emphasizing social relationships, social contexts, and meaning and purpose.

No Intervention: Waitlist control
Waitlist control group. Will receive intervention after arm one is complete.



Primary Outcome Measures :
  1. Impact of Events Scale - Revised (IES-r) [ Time Frame: Pre-test, immediately following 6-week group completion, 3-month, and 6-month. ]

    Change of PTSD symptoms. 22 item questionnaire, each scored 0 to 4 points; Scores higher than 24 are concern for PTSD.

    3 subscales: intrusion subscale (mean range from 0-4), avoidance subscale (mean range from 0-4), hyperarousal subscale (mean range from 0-4).


  2. Patient Health Questionnaire (PHQ-9) [ Time Frame: Pre-test, immediately following 6-week group completion, 3-month, and 6-month. ]
    Change of symptoms of depression. Nine items, each of which is scored 0 to 3 providing a 0-27 severity score with higher values indicating increased severity of depression.

  3. Generalized Anxiety Disorder (GAD-7) [ Time Frame: Pre-test, immediately following 6-week group completion, 3-month, and 6-month. ]
    Change of symptoms of anxiety. Seven items, each of which is scored 0-3 providing a 0-21 severity score with higher value indicating increased severity of anxiety.

  4. Godin Leisure Time Activity Questionnaire [ Time Frame: Pre-test, immediately following 6-week group completion, 3-month, and 6-month. ]
    Change in activity levels. Participant indicates how many times on average they completed exercise (strenuous, moderate, mild) for more than 15-minutes during a typical 7-day period.

  5. Euroqol 5 Dimensions (EQ-5D-5L) [ Time Frame: Pre-test, immediately following 6-week group completion, 3-month, and 6-month. ]
    Change in health status. Participants select their current experience of health on a visual analog scale (VAS) and descriptive system. The descriptive system consists of a 1-5 severity scale (higher values indicating increased severity) for 5 categories of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The VAS records the participant's self-rated health on a vertical, visual analogue scale where the endpoints are labeled "best imaginable health state" and "worst imaginable health state."

  6. Employment questionnaire [ Time Frame: Pre-test, immediately following 6-week group completion, 3-month, and 6-month. ]
    Change of employment status. Participants indicate whether their recent hospital stay has affected their employment by selecting both their current employment status and employment status prior to their hospital stay (i.e. one of the following: employed full-time, employed part-time, unemployed, home-maker, caregiver, student full-time, student part-time, on disability, retired, other).


Secondary Outcome Measures :
  1. Focus Group [ Time Frame: Immediately following 6-week group completion ]
    Qualitative semi-structured focus group developed by the researcher to evaluate the program. Topics include: experiences about the group, benefits of the group, examples of changes, and areas of improvement for group development.

  2. Qualitative Survey [ Time Frame: Immediately following 6-week group completion ]
    Qualitative self-report form (not survey or scale) developed by the researcher to on symptomatic changes post-intervention. Questions inquire about: changes in daily activities, fulfillment of roles, social relationships, confidence in coping abilities, changes to routine, participation in leisure activities, hopes for the future, and plans for maintaining recovery.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria for Patients:

  • Spent more than 4 days in the ICU,
  • Were discharged into the community within 4 months of transfer out of the ICU (excluding patients who were in hospital long-term)
  • Speaks English
  • Has a fixed address
  • Does not have pre-existing psychiatric diagnoses documented in the ICU transfer summary
  • Lives within or surrounding Calgary.

Inclusion Criteria for Caregivers:

  • Caregiver of an ICU survivor participant meeting criteria above
  • Speaks English
  • Has a fixed address
  • Lives within or surrounding Calgary.

Exclusion Criteria for Patients:

- Long-term hospital stay

Excluding Criteria for Caregivers:

- None


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03925181


Locations
Layout table for location information
Canada, Alberta
Calgary ICU Recovery Clinic: Foothills Medical Centre
Calgary, Alberta, Canada, T2N 2T9
Sponsors and Collaborators
University of Calgary
Alberta Health Services
Investigators
Layout table for investigator information
Principal Investigator: Tanya Mudry, PhD University of Calgary
Layout table for additonal information
Responsible Party: Tanya Mudry, Assistant Professor, University of Calgary
ClinicalTrials.gov Identifier: NCT03925181    
Other Study ID Numbers: REB18-2105
First Posted: April 24, 2019    Key Record Dates
Last Update Posted: December 8, 2021
Last Verified: December 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No